History of LTL Pharma
and Long Life Medicines

Long Life Medicines. This is the name we give to the so-called “long-term listed products” that have been in use in medical settings over many years. There are a large number of such drugs still needed to treat patients several decades after they first appeared in the market as innovative new medicines.

Safety and efficacy as well as quality data that have been accumulated in the clinical settings over the years weave the history of our Long Life Medicines.

We succeeded these medicines from the originator pharmaceutical manufacturers who discovered and brought them onto the markets, together with enormous amount of product data. It is the core of our business to achieve stable supply of these products while maintaining or further improving their quality.

History of Marketing Authorization (MA)
transfer of Long Life Medicines

2017-2018

MA of 16 products was transferred from Astellas Pharma Inc.

Emilace® (Nemonapride)
Gaster® (Famotidine)
Sawacillin® (Amoxicillin Hydrate)
Josamycin (Josamycin)*
Josamy® (Josamycin Propionate)*
Spongel® (Gelatin)*
Cefamezin®α (Cefazolin Sodium Hydrate)
Cefzon® (Cefdinir)
Solantal® (Tiaramide Hydrochloride)
Nasea® (Ramosetron Hydrochloride)
Neurovitan® (Octotiamine・Riboflavin・Pyridoxine Hydrochloride・Cyanocobalamin)
Nivadil® (Nilvadipine)
Perdipine® (Nicardipine Hydrochloride)
Hypoca® (Barnidipine Hydrochloride)
Lowgan® (Amosulalol Hydrochloride)
Lodopin® (Zotepine)®

2019

Distribution of 2 products was transferred from Leo Pharma

Nerisona® (Diflucortolone Valerate)**
Neriproct® (Diflucortolone Valerate・Lidocaine)*

2020

MA of 1 product was transferred from Sanofi K.K.

Dellegra® (Fexofenadine Hydrochloride・Pseudoephedrine Hydrochloride)

2024

MA of 1 product was transferred from Chugai Pharmaceutical Co., Ltd.

Oxarol® (Maxacalcitol)

MA of 1 product was transferred from Astellas Pharma Inc.

Seroquel® (Quetiapine Fumarate)

2026

MA transfer of 7 products was agreed with Teijin Pharma Ltd.

( ): Generic name
*Sales discontinuation
**Distribution was returned to MAH.